Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

NCT07717268 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
51
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic

Collaborators